Table 1.

Types of prophylactic HPV vaccines in Mexico and recommendations through the years.

Year	Recommendations	HPV Vaccines
2009	Routine vaccination of a single birth cohort of girls aged 9–13 y with a 3-dose schedule	Bivalent Qudrivalent
2014	2-dose schedule, if starting series at age 9–14 y; 3-dose schedule for older girls/women or for immunocompromised persons	Bivalente Quadrivalent
2017	Vaccination of multiple cohorts of girls aged 9–14 y when vaccine first introduced; vaccination of other populations (females aged ≥15 y or males), only if feasible, affordable, cost-effective, and not diverting resources from primary target population or from cervical cancer screening programs	Bivalent Qudrivalent
2019	Owing to the global vaccine supply/demand imbalance, target girls aged 13 or 14 y, before they age out of the recommended primary target population, or schedule an extended interval of 3–5 y between the 2 doses, with dose 1 given to girls aged 9 or 10 y	Bivalent Qudrivalent
2022	A one or two-dose schedule for girls aged 9-14 years A one or two-dose schedule for girls and women aged 15-20 years Two doses with a 6-month interval for women older than 21 years	Bivalent Qudrivalent 9-valent HPV vaccine